Culbertson A N & Co Inc decreased Procter And Gamble Co (PG) stake by 7.03% reported in 2018Q1 SEC filing. Culbertson A N & Co Inc sold 5,285 shares as Procter And Gamble Co (PG)’s stock declined 8.97%. The Culbertson A N & Co Inc holds 69,892 shares with $5.54M value, down from 75,177 last quarter. Procter And Gamble Co now has $194.71 billion valuation. The stock increased 1.30% or $0.99 during the last trading session, reaching $77.43. About 11.82 million shares traded or 25.15% up from the average. The Procter & Gamble Company (NYSE:PG) has declined 14.45% since June 24, 2017 and is downtrending. It has underperformed by 27.02% the S&P500. Some Historical PG News: 29/05/2018 – PLUG POWER SAYS CO.’S FUEL CELL POWERED FORKLIFT IN PG ACCIDENT; 22/03/2018 – Gillette Launches Latest Innovations and Upgrades with a Strong Declaration That “One Size” Does Not, in Fact, Fit All Men; 18/04/2018 – Procter & Gamble Co expected to post earnings of 98 cents a share – Earnings Preview; 06/03/2018 – P&G to bring marketing […]; 23/04/2018 – CincinnatiBusCou: EXCLUSIVE: P&G’s Blue Ash campus sold; 06/04/2018 – S&PGR Lowers Rating On Riftstone Trust Series 2015-1 PG; 19/04/2018 – TEVA & PROCTER & GAMBLE CO. HAVE AGREED TO TERMINATE PGT; 24/05/2018 – KALB 5: Multiple sources say fatal explosion happened at P&G Thursday morning; 19/04/2018 – MOODY’S AFFIRMS PROCTER & GAMBLE’S Aa3 RATING FOLLOWING ANNOUNC; 07/04/2018 – Mumbai Bourse: Press Release From PG Electroplast Ltd
Hilltop Holdings Inc increased Johnson & Johnson (JNJ) stake by 32.91% reported in 2018Q1 SEC filing. Hilltop Holdings Inc acquired 6,706 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Hilltop Holdings Inc holds 27,085 shares with $3.47M value, up from 20,379 last quarter. Johnson & Johnson now has $329.48B valuation. The stock increased 1.14% or $1.39 during the last trading session, reaching $122.84. About 10.31 million shares traded or 54.79% up from the average. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 24, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 16/03/2018 – J&J Reaches $2.1 Billion Deal to Sell Diabetes Device Business; 16/03/2018 – RPT-J&J says offered $2.1 bln for Lifescan diabetes business; 27/03/2018 – FDA: Johnson & Johnson Consumer, Inc.- Johnson & Johnson BAND-AID® Brand First Aid Products HURT-FREE® Wrap (size: 2in); 14/05/2018 – DEPUY SYNTHES PRODUCTS – SIGNED AGREEMENT TO ACQUIRE ASSETS OF MEDICAL ENTERPRISES DISTRIBUTION; FINANCIAL TERMS OF DEAL ARE NOT BEING DISCLOSED; 23/04/2018 – DJ Johnson & Johnson, Inst Holders, 1Q 2018 (JNJ); 01/04/2018 – FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investor; 16/03/2018 – J&J nears diabetes device exit with $2.1 bln LifeScan sale; 02/05/2018 – Johnson & Johnson’s Janssen Biotech to Acquire BeneVir Biopharm; 11/04/2018 – JOHNSON & JOHNSON JNJ.N , IMERYS SA IMTP.PA SUBSIDIARY ORDERED TO PAY $80 MLN IN PUNITIVE DAMAGES IN NEW JERSEY CASE BLAMING TALC FOR MESOTHELIOMA -COURTROOM VIDEO; 16/04/2018 – JANSSEN – COS TO SHARE DEVELOPMENT COSTS, COMMERCIAL PROFITS AND LOSSES; ADDITIONAL TERMS OF AGREEMENT NOT DISCLOSED
Since February 15, 2018, it had 0 buys, and 1 sale for $20.17 million activity. Stoffels Paulus sold $20.17M worth of stock or 155,342 shares.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, October 18. Wells Fargo maintained the shares of JNJ in report on Wednesday, October 18 with “Buy” rating. Citigroup maintained it with “Buy” rating and $149 target in Monday, October 23 report. The rating was initiated by Atlantic Securities with “Neutral” on Friday, December 18. Argus Research upgraded it to “Buy” rating and $145 target in Wednesday, July 20 report. The stock has “Buy” rating by Jefferies on Friday, March 23. The stock of Johnson & Johnson (NYSE:JNJ) has “Sell” rating given on Wednesday, September 20 by Goldman Sachs. JP Morgan downgraded the shares of JNJ in report on Tuesday, January 2 to “Neutral” rating. The firm earned “Buy” rating on Thursday, May 17 by Leerink Swann. The stock has “Buy” rating by Credit Suisse on Tuesday, June 12.
Hilltop Holdings Inc decreased Ishares Tr (TLT) stake by 244,623 shares to 19,855 valued at $2.42M in 2018Q1. It also reduced Voya Glbl Eqty Div & Prem Op (IGD) stake by 59,695 shares and now owns 11,600 shares. Apple Inc (NASDAQ:AAPL) was reduced too.
Investors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It increased, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Ntv Asset Mngmt holds 33,516 shares or 1.22% of its portfolio. Connor Clark Lunn Investment Mgmt stated it has 636,395 shares or 0.49% of all its holdings. American Investment Svcs Inc stated it has 1,655 shares or 0.07% of all its holdings. Moreover, M&R Capital Mgmt Incorporated has 1.87% invested in Johnson & Johnson (NYSE:JNJ). Asset Group Incorporated Inc invested in 1.08% or 23,458 shares. State Farm Mutual Automobile Co holds 37.88 million shares or 6.55% of its portfolio. Connable Office owns 0.61% invested in Johnson & Johnson (NYSE:JNJ) for 24,061 shares. Fukoku Mutual Life stated it has 11,550 shares or 0.23% of all its holdings. Capital City Fl invested in 2.44% or 44,208 shares. Kornitzer Capital Management Ks holds 1.08% or 491,750 shares. Deutsche National Bank & Trust Ag reported 1.05% of its portfolio in Johnson & Johnson (NYSE:JNJ). Icon Advisers Incorporated Company holds 0.02% or 2,100 shares. Cibc Asset reported 322,616 shares. Blume Cap Mgmt accumulated 4.25% or 59,643 shares. Hartline Investment invested 0.06% of its portfolio in Johnson & Johnson (NYSE:JNJ).
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Buy Johnson & Johnson” on June 20, 2018, also Seekingalpha.com with their article: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” published on June 01, 2018, Forbes.com published: “What Are Johnson & Johnson’s Key Sources Of Revenue?” on June 20, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” published on June 20, 2018 as well as Streetinsider.com‘s news article titled: “Johnson & Johnson (JNJ) Worldwide Chairman Sandra E. Peterson to Retire” with publication date: June 22, 2018.
Investors sentiment decreased to 0.78 in 2018 Q1. Its down 0.11, from 0.89 in 2017Q4. It turned negative, as 71 investors sold PG shares while 786 reduced holdings. 112 funds opened positions while 556 raised stakes. 1.51 billion shares or 2.21% more from 1.47 billion shares in 2017Q4 were reported. Hourglass Capital Ltd Liability holds 0.13% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 7,046 shares. Hartline reported 0.16% stake. Old Second Retail Bank Of Aurora has invested 1.85% in The Procter & Gamble Company (NYSE:PG). Plante Moran Advsr Limited Company, Michigan-based fund reported 15,732 shares. Dodge And Cox has 136,866 shares. 10,061 were accumulated by Gould Asset Mngmt Limited Liability Co Ca. 1.20 million are held by Amp Invsts Limited. Wharton Business Group Limited Com holds 0.04% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 5,107 shares. Annex Advisory Ser Limited Liability Com holds 0.05% or 3,179 shares. Jarislowsky Fraser Ltd reported 1.82 million shares or 0.9% of all its holdings. New Mexico Educational Retirement Board has 0.73% invested in The Procter & Gamble Company (NYSE:PG). Scotia Cap owns 448,695 shares for 0.49% of their portfolio. Icon Advisers Incorporated invested in 9,100 shares. Telos Inc owns 29,618 shares or 0.83% of their US portfolio. King Luther Cap Corporation accumulated 1.15 million shares.
More notable recent The Procter & Gamble Company (NYSE:PG) news were published by: Seekingalpha.com which released: “It Is No Longer A Gamble Investing In Procter & Gamble: Part 5” on June 14, 2018, also Seekingalpha.com with their article: “Lanny’s Recent Stock Purchase – Procter & Gamble” published on June 09, 2018, 247Wallst.com published: “General Electric Exits the Dow as Year’s Worst Performing Stock” on June 23, 2018. More interesting news about The Procter & Gamble Company (NYSE:PG) were released by: Livetradingnews.com and their article: “The Procter & Gamble Company (NYSE:PG) Encouraging Extending Gains” published on May 29, 2018 as well as Bizjournals.com‘s news article titled: “EXCLUSIVE: P&G shuffles executive leadership” with publication date: June 21, 2018.
Among 25 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 14 Hold. Therefore 40% are positive. Proctor & Gamble has $106 highest and $61.0 lowest target. $90.02’s average target is 16.26% above currents $77.43 stock price. Proctor & Gamble had 90 analyst reports since August 4, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Hold” rating and $8000 target in Friday, June 30 report. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Thursday, April 12 by Bank of America. The firm earned “Buy” rating on Friday, August 26 by Johnson Rice. The firm has “Hold” rating given on Tuesday, April 17 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, January 27 by Goldman Sachs. On Friday, August 7 the stock rating was downgraded by Vetr to “Strong-Buy”. The firm has “Hold” rating given on Tuesday, August 4 by TheStreet. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Wednesday, June 15 by Jefferies. The rating was maintained by RBC Capital Markets with “Hold” on Tuesday, August 1. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Monday, August 15 by B. Riley & Co.
Since February 15, 2018, it had 0 insider purchases, and 10 selling transactions for $8.44 million activity. The insider Giovanni Ciserani sold $931,536. 8,502 The Procter & Gamble Company (NYSE:PG) shares with value of $668,179 were sold by Pritchard Marc S.. $113,533 worth of The Procter & Gamble Company (NYSE:PG) shares were sold by Coombe Gary A. Posada Juan Fernando had sold 9,005 shares worth $739,189 on Thursday, February 15. The insider Fish Kathleen B sold $103,190. $149,130 worth of The Procter & Gamble Company (NYSE:PG) shares were sold by Bishop Steven D. Schomburger Jeffrey K also sold $3.07M worth of The Procter & Gamble Company (NYSE:PG) on Thursday, February 15.
Analysts await The Procter & Gamble Company (NYSE:PG) to report earnings on July, 26. They expect $0.91 EPS, up 7.06% or $0.06 from last year’s $0.85 per share. PG’s profit will be $2.29B for 21.27 P/E if the $0.91 EPS becomes a reality. After $1.00 actual EPS reported by The Procter & Gamble Company for the previous quarter, Wall Street now forecasts -9.00% negative EPS growth.